Holen Sie sich die Stockscreener-App
13.08
1.79%
0.23
Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.07%
79.51
|
77.91 | 56.35 | 49.68 | 46.02 |
| Interest Income/Expense |
12.70%
0.055
|
0.063 | 0.07 | 0.035 | 0.04 |
| Operating Income/Loss |
2.07%
-79.51
|
-77.91 | -56.35 | -49.68 | -46.02 |
| Nonoperating Income/Loss |
30.96%
7.114
|
5.432 | 5.209 | 5.063 | 4.889 |
| Income/Loss From Continuing Operations Before Tax |
0.10%
-72.40
|
-72.47 | -51.15 | -44.62 | -41.13 |
| Income/Loss From Continuing Operations After Tax |
0.10%
-72.40
|
-72.47 | -51.15 | -44.62 | -41.13 |
|
Net Income/Loss
|
0.10%
-72.40
|
-72.47 | -51.15 | -44.62 | -41.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
11,660%
85.21
|
0.7246 | 69.86 | 69.64 | 69.44 |
| Diluted Average Shares |
11,660%
85.21
|
0.7246 | 69.86 | 69.64 | 69.44 |
| Basic Earnings Per Share |
15.84%
-0.85
|
-1.01 | -0.73 | -0.64 | -0.59 |
| Diluted Earnings Per Share |
15.84%
-0.85
|
-1.01 | -0.73 | -0.64 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):